How embracing opposition sends clinicians home from COPHy with more useful takeaways

News
Video

The Congress on Controversies in Ophthalmology highlights debates, but also discussions

The Congress on Controversies in Ophthalmology (COPHy) is underway in Seville, Spain. This year, the 16th annual congress will run from 4-5 April, and ahead of the meeting, the Ophthalmology Times Europe team spoke with the COPHy co-chairs for the March/April cover story. Here, we see a clip from one of those interviews. Anat Loewenstein, MD, head of the Department of Ophthalmology at the Tel Aviv Medical Center in Tel Aviv, Israel, serves as a co-chair for the meeting and was happy to explain what makes COPHy different from other ophthalmology conferences. Watch the full video, or continue reading for a brief summary of the conversation.

One unique aspect of the COPHy meetings is its focus on controversial clinical topics. Each session includes three debates, in which two clinicians go head-to-head with affirmative and negative positions. Following each debate, there are ample 10-minute discussion periods, allowing for in-depth analysis. This structure also utilises skilled moderators, who facilitate a comprehensive summary of the debate and aim to synthesize together a conclusion of the debated points. According to Prof Loewenstein, this unique structure has the potential to influence clinical management practices significantly.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.